Lung Cancer Center
From accurate diagnosis to surgery, systemic therapy, radiation therapy, and follow-up care, the Lung Cancer Center provides integrated, patient-centered treatment tailored to each patient's condition and the characteristics of their lung cancer.
The Lung Cancer Center at Inje University Ilsan Paik Hospital provides personalized treatment based on the characteristics of each patient's lung cancer and overall health condition. Even among patients with the same diagnosis, treatment strategies may differ depending on the type and stage of cancer, tumor location and size, presence of metastasis, pathological and molecular characteristics, and the patient's overall health.
To address these individual differences, specialists from multiple medical fields work together as part of a multidisciplinary care system. The treatment plan may include surgery, systemic therapy, radiation therapy, or a combination of treatments depending on the patient's condition and the characteristics of the cancer.
The goal of treatment is not only to control or treat the cancer, but also to preserve normal lung function and daily activities whenever possible while considering the patient's long-term health and quality of life.
Treatment strategies for lung cancer vary according to cancer stage and individual characteristics. Specialists from different fields review diagnostic findings and the patient's condition together to determine whether surgery, systemic therapy, radiation therapy, or combined treatment is appropriate.
Thoracic surgeons consider the patient's condition, tumor location, extent of disease, and other clinical factors when selecting the appropriate surgical approach. Video-assisted thoracoscopic surgery and other surgical techniques may be considered when clinically appropriate.
Medical oncologists develop systemic treatment plans based on the type and stage of lung cancer, pathological and molecular characteristics, biomarkers, and the patient's overall health.
Radiation oncologists develop individualized treatment plans based on tumor location and size, surrounding normal organs, disease stage, and the purpose of treatment.
Specialists in Radiology and Pathology provide essential diagnostic information regarding tumor location, extent, histological type, and other characteristics that help guide treatment.
As part of a university hospital system with multiple specialized departments and diagnostic and treatment resources, the Lung Cancer Center can coordinate the various areas of care that may be required throughout the patient's treatment journey.
Lung cancer is a malignant tumor that develops when genetic changes cause abnormal cells in the lung to grow and multiply uncontrollably. Cancer may invade nearby tissues or lymph nodes and, in advanced cases, may spread to distant organs.
Non-small cell lung cancer is the most common category of lung cancer and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Depending on the stage and characteristics of the tumor, treatment may include surgery, systemic therapy, radiation therapy, targeted therapy, immunotherapy, or combinations of these approaches.
Small cell lung cancer tends to grow and spread rapidly, making accurate staging particularly important. Treatment commonly centers on systemic therapy and radiation therapy, with the specific strategy determined according to the stage and overall condition of the patient.
Lung cancer treatment requires the comprehensive review of diagnostic, imaging, pathological, surgical, medical oncology, and radiation oncology information. The Lung Cancer Center brings together specialists from relevant fields to discuss diagnostic findings and determine an individualized treatment strategy.
Diagnosing lung cancer involves more than determining whether an abnormality is present in the lung. Physicians evaluate the location and size of the tumor, involvement of lymph nodes or other organs, histological type, molecular characteristics, and overall disease stage.
| Chest CT | Chest computed tomography (CT) is used to evaluate pulmonary nodules and masses, including their size, location, relationship to surrounding structures, and associated lymph node abnormalities. |
|---|---|
| Low-Dose Chest CT | Low-dose CT may be used for lung cancer screening in people at increased risk of lung cancer. Eligibility for screening should be determined based on factors such as age and smoking history. |
| Bronchoscopy and Biopsy | Bronchoscopy allows physicians to examine the airways and obtain tissue samples when appropriate. Pathological examination of the tissue can determine whether cancer is present and identify its type. |
| Percutaneous Lung Biopsy | For selected lung lesions that are difficult to reach through bronchoscopy, tissue may be obtained through image-guided percutaneous biopsy. |
| PET-CT | PET-CT may be used for comprehensive staging and evaluation of possible distant metastases. |
| Pathological and Molecular Testing | Pathological testing identifies the histological type of lung cancer, while molecular and biomarker testing may provide information needed to determine appropriate targeted or immunotherapy options. |
Lung cancer treatment requires consideration of not only the cancer itself, but also cardiopulmonary function, other chronic diseases, nutritional status, surgical eligibility, and overall health. A university hospital provides access to multiple specialized departments and diagnostic and treatment resources that can be coordinated for patients requiring complex or multidisciplinary care.
Expertise in respiratory medicine, surgery, systemic therapy, radiation therapy, imaging, and pathology can be integrated throughout the patient's care.
Patients with cardiovascular disease, diabetes, kidney disease, or other medical conditions may receive coordinated care with the relevant specialties when necessary.
CT, PET-CT, tissue biopsy, pathological examination, and molecular testing can be combined to provide information needed for treatment planning.
Treatment planning considers surgery, systemic therapy, radiation therapy, and combinations of these approaches according to the patient's disease and condition.
After treatment, patients can receive follow-up evaluation for recurrence and treatment-related changes, with additional testing and specialist care arranged when necessary.
Treatment decisions take into account not only medical findings, but also the patient's overall health, daily life, treatment goals, and individual circumstances.
The surgical approach and extent of resection are determined by considering the type and stage of lung cancer, tumor location and size, pulmonary function, and the patient's overall condition.
Video-assisted thoracoscopic surgery (VATS) is a minimally invasive surgical approach performed through small incisions using a camera and surgical instruments. Its use is determined according to the patient's condition and surgical indications.
When appropriate, surgeons may consider an approach that removes the necessary portion of the lung while preserving as much healthy lung tissue as possible, based on tumor location, extent of disease, and pulmonary function.
When a larger resection is required because of tumor size, location, or involvement of surrounding structures, the extent of surgery is determined based on the patient's overall condition and the characteristics of the disease.
Systemic therapy is selected according to the type and stage of lung cancer, molecular and pathological characteristics of the tumor, biomarkers, previous treatments, and the patient's overall condition.
Cytotoxic chemotherapy uses anticancer drugs to inhibit the growth and multiplication of cancer cells. Depending on the type, stage, and treatment goals, chemotherapy may be used alone or in combination with other treatments.
In selected patients with non-small cell lung cancer, targeted therapies may be considered when specific molecular alterations are identified.
Immune checkpoint inhibitors and other immunotherapy approaches may be considered based on tumor characteristics, biomarkers, disease stage, previous treatment, and the patient's overall condition.
Depending on the disease stage and treatment goals, radiation therapy may be used before or after surgery, together with systemic therapy, as a local treatment for patients who are not candidates for surgery, or for symptom relief in advanced disease.
Treatment fields and radiation doses are planned using imaging to identify the tumor and surrounding normal tissues.
Radiation treatment methods and schedules are selected based on the patient's disease stage, treatment goals, overall condition, and the location and characteristics of the tumor.
Lung cancer may cause few or no symptoms in its early stages. For people at increased risk, appropriate screening can help detect lung cancer at an earlier stage. Low-dose chest CT has been shown to reduce lung cancer mortality in high-risk populations when used as a screening test.
In the U.S. National Lung Screening Trial (NLST), a large randomized study supported by the National Cancer Institute, screening with low-dose CT was associated with approximately a 20% reduction in lung cancer mortality compared with chest X-ray among high-risk participants. Low-dose CT is not recommended indiscriminately for everyone; screening eligibility should be determined based on individual risk factors such as age and smoking history.
Inje University Ilsan Paik Hospital provides a One-Stop service for selected patients, allowing chest CT and consultation regarding the results to be coordinated within the same visit when applicable. This helps connect patients with suspected lung cancer, pulmonary nodules, or other abnormal findings to the appropriate diagnostic and specialist care.
Lung cancer may not cause noticeable symptoms in its early stages. If respiratory symptoms persist or change, medical evaluation may be appropriate to determine the underlying cause.
※ These symptoms do not necessarily indicate lung cancer. If symptoms persist or worsen, consult a medical professional.
Treatment planning considers not only the type and stage of lung cancer, but also pathological and molecular characteristics and the patient's overall condition.
When surgery is appropriate, the most suitable surgical approach is considered. When systemic or radiation therapy is needed, the relevant specialists coordinate treatment.
Imaging, biopsy, pathology, and molecular test results are integrated into treatment planning so that appropriate care can follow an accurate diagnosis.
Treatment planning considers not only cancer control, but also pulmonary function, physical function, daily activities, and the burden of treatment.
Smoking is one of the most important risk factors for lung cancer. For people who smoke, quitting is an important step toward reducing lung cancer risk.
People at increased risk should discuss the potential benefits and eligibility for lung cancer screening with a healthcare professional, considering factors such as age and smoking history.
When a pulmonary nodule is detected on CT or another imaging study, follow-up or additional testing may be recommended based on its size, appearance, changes over time, and individual risk factors.
People with chronic respiratory diseases should maintain regular medical care and appropriate health management to support long-term lung health.
Lung cancer can develop without noticeable symptoms, particularly in its early stages. People at increased risk should discuss screening with a healthcare professional based on factors such as age, smoking history, and medical history.
No. Not all pulmonary nodules are cancerous. Physicians consider the size, shape, location, changes over time, and individual risk factors when deciding whether additional testing or follow-up imaging is appropriate.
Treatment depends on the type and stage of lung cancer and the patient's overall condition. In addition to surgery, treatment may include systemic therapy, radiation therapy, targeted therapy, immunotherapy, or combinations of these approaches.
The surgical approach depends on the tumor's location and size, disease stage, and the patient's condition. Minimally invasive approaches such as video-assisted thoracoscopic surgery may be considered when clinically appropriate.
Some lung cancers can be treated primarily with surgery, systemic therapy, or radiation therapy, while others require multiple treatments in sequence or in combination. Multidisciplinary review allows specialists to consider diagnostic findings and the patient's condition together when developing an overall treatment strategy.
For accurate diagnosis and individualized treatment of lung cancer and pulmonary nodules, consult with our specialized medical team.